BR0309085A - Medicamento que contém esteróides e agente anticolinérgico - Google Patents
Medicamento que contém esteróides e agente anticolinérgicoInfo
- Publication number
- BR0309085A BR0309085A BR0309085-0A BR0309085A BR0309085A BR 0309085 A BR0309085 A BR 0309085A BR 0309085 A BR0309085 A BR 0309085A BR 0309085 A BR0309085 A BR 0309085A
- Authority
- BR
- Brazil
- Prior art keywords
- anticholinergic agent
- drug containing
- containing steroids
- steroids
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
"MEDICAMENTO QUE CONTéM ESTERóIDES E AGENTE ANTICOLINéRGICO". A presente invenção refere-se a novas composições de medicamentos na base de esteróides de longa eficácia e sais de um novo agente anticolinérgico, a processos para produção das mesmas, bem como ao uso das mesmas na terapia de doenças das vias respiratórias.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10216429A DE10216429A1 (de) | 2002-04-12 | 2002-04-12 | Arzneimittel enthaltend Steroide und ein neues Anticholinergikum |
PCT/EP2003/003668 WO2003086399A1 (de) | 2002-04-12 | 2003-04-09 | Arzneimittel enthaltend steroide und ein neues anticholinergikum |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0309085A true BR0309085A (pt) | 2005-02-09 |
Family
ID=28458802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0309085-0A Expired - Fee Related BR0309085A (pt) | 2002-04-12 | 2003-04-09 | Medicamento que contém esteróides e agente anticolinérgico |
Country Status (29)
Country | Link |
---|---|
EP (2) | EP1496902B1 (pt) |
JP (1) | JP4559086B2 (pt) |
KR (1) | KR101010869B1 (pt) |
CN (1) | CN1646126A (pt) |
AR (1) | AR039275A1 (pt) |
AT (1) | ATE312607T1 (pt) |
AU (1) | AU2003216921B2 (pt) |
BR (1) | BR0309085A (pt) |
CA (1) | CA2481268C (pt) |
DE (2) | DE10216429A1 (pt) |
DK (1) | DK1496902T3 (pt) |
EA (1) | EA008386B1 (pt) |
EC (1) | ECSP045355A (pt) |
ES (1) | ES2254917T3 (pt) |
HR (1) | HRP20040943B1 (pt) |
IL (2) | IL164391A0 (pt) |
ME (1) | MEP54208A (pt) |
MX (1) | MXPA04009917A (pt) |
MY (1) | MY137045A (pt) |
NO (1) | NO20044097L (pt) |
NZ (1) | NZ536284A (pt) |
PE (1) | PE20040326A1 (pt) |
PL (1) | PL211227B1 (pt) |
RS (1) | RS50776B (pt) |
TW (1) | TWI311055B (pt) |
UA (1) | UA80125C2 (pt) |
UY (1) | UY27758A1 (pt) |
WO (1) | WO2003086399A1 (pt) |
ZA (1) | ZA200406751B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
JP4819699B2 (ja) * | 2004-02-06 | 2011-11-24 | メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト | 喘息及びcopdの長期間の治療のための抗コリン作用薬及びグルココルチコイドの組合せ剤 |
EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
AU2010253776B2 (en) | 2009-05-29 | 2015-01-22 | Pearl Therapeutics, Inc. | Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting B2 adrenergic receptor agonists and associated methods and systems |
EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
WO2014144894A1 (en) | 2013-03-15 | 2014-09-18 | Pearl Therapeutics, Inc. | Methods and systems for conditioning of particulate crystalline materials |
CN115282411A (zh) * | 2022-01-14 | 2022-11-04 | 温州医科大学 | 利用鼻嗅区递送药物入脑的输送系统及其应用方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
GR861995B (en) | 1985-07-30 | 1986-11-04 | Glaxo Group Ltd | Devices for administering medicaments to patients |
SG45171A1 (en) | 1990-03-21 | 1998-01-16 | Boehringer Ingelheim Int | Atomising devices and methods |
DE4108393A1 (de) | 1991-03-15 | 1992-09-17 | Boehringer Ingelheim Kg | Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln |
IL107120A (en) | 1992-09-29 | 1997-09-30 | Boehringer Ingelheim Int | Atomising nozzle and filter and spray generating device |
DE4318455A1 (de) | 1993-06-03 | 1994-12-08 | Boehringer Ingelheim Kg | Kapselhalterung |
KR19990008109A (ko) * | 1995-04-28 | 1999-01-25 | 나가사까 겐지로 | 1,4-이치환 피페리딘 유도체 |
DE19536903C2 (de) | 1995-10-04 | 1998-09-10 | Boehringer Ingelheim Int | Vorrichtung zum Haltern eines fluidischen Bauteils |
DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
DE19545226C1 (de) | 1995-12-05 | 1997-06-19 | Boehringer Ingelheim Int | Sperrspannwerk für einen federbetätigten Abtrieb |
GB0009591D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Medical combinations |
DE10050994A1 (de) * | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung |
AU2002210575A1 (en) * | 2000-10-31 | 2002-05-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Novel medicament compositions based on anticholinergics and corticosteroids |
-
2002
- 2002-04-12 DE DE10216429A patent/DE10216429A1/de not_active Withdrawn
-
2003
- 2003-04-09 EA EA200401303A patent/EA008386B1/ru not_active IP Right Cessation
- 2003-04-09 CN CNA038083299A patent/CN1646126A/zh active Pending
- 2003-04-09 EP EP03712137A patent/EP1496902B1/de not_active Expired - Lifetime
- 2003-04-09 EP EP05109887A patent/EP1621197A3/de not_active Withdrawn
- 2003-04-09 KR KR1020047016335A patent/KR101010869B1/ko not_active IP Right Cessation
- 2003-04-09 AU AU2003216921A patent/AU2003216921B2/en not_active Expired
- 2003-04-09 MX MXPA04009917A patent/MXPA04009917A/es active IP Right Grant
- 2003-04-09 ES ES03712137T patent/ES2254917T3/es not_active Expired - Lifetime
- 2003-04-09 ME MEP-542/08A patent/MEP54208A/xx unknown
- 2003-04-09 PL PL371561A patent/PL211227B1/pl not_active IP Right Cessation
- 2003-04-09 DK DK03712137T patent/DK1496902T3/da active
- 2003-04-09 DE DE50301934T patent/DE50301934D1/de not_active Expired - Lifetime
- 2003-04-09 AR ARP030101241A patent/AR039275A1/es active Pending
- 2003-04-09 JP JP2003583418A patent/JP4559086B2/ja not_active Expired - Lifetime
- 2003-04-09 AT AT03712137T patent/ATE312607T1/de active
- 2003-04-09 BR BR0309085-0A patent/BR0309085A/pt not_active Expired - Fee Related
- 2003-04-09 WO PCT/EP2003/003668 patent/WO2003086399A1/de active IP Right Grant
- 2003-04-09 RS YUP-899/04A patent/RS50776B/sr unknown
- 2003-04-09 NZ NZ536284A patent/NZ536284A/en not_active IP Right Cessation
- 2003-04-09 IL IL16439103A patent/IL164391A0/xx unknown
- 2003-04-09 CA CA2481268A patent/CA2481268C/en not_active Expired - Lifetime
- 2003-04-10 TW TW092108227A patent/TWI311055B/zh not_active IP Right Cessation
- 2003-04-10 UY UY27758A patent/UY27758A1/es not_active Application Discontinuation
- 2003-04-10 MY MYPI20031320A patent/MY137045A/en unknown
- 2003-04-10 PE PE2003000365A patent/PE20040326A1/es not_active Application Discontinuation
- 2003-09-04 UA UA20041109192A patent/UA80125C2/uk unknown
-
2004
- 2004-08-25 ZA ZA200406751A patent/ZA200406751B/en unknown
- 2004-09-27 NO NO20044097A patent/NO20044097L/no not_active Application Discontinuation
- 2004-10-04 IL IL164391A patent/IL164391A/en not_active IP Right Cessation
- 2004-10-11 HR HRP20040943AA patent/HRP20040943B1/hr not_active IP Right Cessation
- 2004-10-11 EC EC2004005355A patent/ECSP045355A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP034571A (es) | Nuevas composiciones de medicamentos a base de sales de tiotropio y sales del salmeterol | |
UY26992A1 (es) | Nuevas composiciones de medicamentos sobre la base de agentes anticolinérgicos y corticoesteroides | |
MEP36608A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
UY27759A1 (es) | Combinaciones de medicamentos que contienen compuestos heterocíclicos y un nuevo agente anticolinérgico. | |
AR049985A1 (es) | Tratamiento de combinacion para enfermedades malignas no hematologicas | |
ECSP034732A (es) | Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias | |
AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
ECSP055524A (es) | Derivados de indolin-fenilsufonamida | |
IL154888A (en) | Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid | |
BR0207883A (pt) | Composições de medicamentos à base de anticolenérgicos e inibidores de pde-iv | |
ECSP088405A (es) | Nuevos derivados de pirimidina y su uso en terapia, así como el uso de derivados de pirimidina en la fabricación de un medicamento para la prevención y/o tratamiento de la enfermedad de alzheimer | |
UY27757A1 (es) | Medicamento que contiene betamiméticos y un nuevo anticolinérgico. | |
IL226313A0 (en) | A method for producing gamma-carboxylated human prothrombin, isolated prothrombin produced by such a method, a pharmaceutical preparation including it and its use as drugs and for the production of drugs for the treatment of blood coagulation | |
BR0109672A (pt) | Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente | |
UA110463C2 (ru) | ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ 4-{[9-ХЛОР-7-(2-ФТОР-6-МЕТОКСИФЕНІЛ)-5Н-ПІРИМІДО[5,4-d][2]БЕНЗАЗЕПІН-2-ІЛ]АМІНО}-2-МЕТОКСИБЕНЗОЙНОЇ КИСЛОТИ ДЛЯ ЛІКУВАННЯ РАКУ Й ІНШИХ ЗАХВОРЮВАНЬ І ПОРУШЕНЬ СТАНУ ЗДОРОВ'Я | |
BR0309085A (pt) | Medicamento que contém esteróides e agente anticolinérgico | |
BRPI0413129A (pt) | medicamentos para inalação compreendendo betamiméticos e anticolinérgico | |
BRPI0416188A (pt) | formulações de medicamentos que contêm aromatizante, com propriedades farmacêuticas aperfeiçoadas | |
BR0306663A (pt) | Formulação de salmeterol superfino | |
AR021086A1 (es) | Omega-amidas de n-arilsulfonil-aminoacidos, un procedimiento para su preparacion, medicamento, uso de dichos compuestos para la preparacion de un medicamento y procedimiento para la preparacion de un medicamento. | |
BRPI0416136A (pt) | processo para a produção de sais de tiotrópio, sais de tiotrópio, bem como formulações de medicamentos contendo os mesmos | |
BR0307703A (pt) | Composições de medicamentos na base de agentes anticolinérgicos e inibidores de quinase de egfr | |
BR0207866A (pt) | Uso de flumazenil na preparação de um medicamento para o tratamento da dependência de cocaìna | |
GT200400134A (es) | Sistemas emulsionantes que contienen derivados de azetidina | |
AR036518A1 (es) | Nuevos medicamentos para la inhalacion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA: INT. CL. A61K 31/46, 31/56; A61P 11/06, 11/16, 29/00, 43/00, 11/00 Ipc: A61K 31/46 (2011.01), A61K 31/56 (2011.01), A61P 1 |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014. |